Trevi Therapeutics Inc (TRVI)

Operating Expenses

$20.51M

Quarterly · Period ending: · USD

TRVI logo

TRVI Operating Expenses

Latest reported$20.51M
TRVI Quarterly Operating Expenses ($2.23M → $20.51M)
High-resolution chart · PNG

TRVI operating expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Trevi Therapeutics Inc Operating Expenses — Quarterly (USD)
Period endingOperating Expenses (USD)
20,509,000
14,912,000
10,220,000
13,916,000
13,722,000
11,470,000
12,205,000
14,087,000
13,251,000
11,871,000
8,898,000
9,045,000
8,382,000
7,563,000
6,657,000
8,405,000
7,820,000
7,025,000
8,273,000
6,947,000
9,167,000
8,089,000
9,193,000
7,244,000
7,413,000
8,639,000
6,766,000
7,650,000
7,417,000
4,812,000
5,929,000
4,957,000
4,380,000
3,142,000
2,232,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.